Stocktoria

PRECISION BIOSCIENCES INC DTIL

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2019-03-28 · LEI

PRECISION BIOSCIENCES INC statistics & valuation

Market cap$188.1M
P / S5.5×
P / B2.0×
Net margin-133.4%
Return on equity-49.6%
Return on capital-35.8%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-423.00% -8.70% -448.90% -26.50% -444.80% -125.80% 10.40% -133.40% 20182019202020212022202320242025
Gross margin (%)
20182019202020212022202320242025
Operating margin (%)
-440.20% -8.10% -452.20% -34.10% -248.30% -89.80% -38.10% -152.20% 20182019202020212022202320242025
Return on equity (%)
-115.20% -67.10% -245.40% -33.60% -184.70% -325.10% 12.70% -49.60% 20182019202020212022202320242025
Shares outstanding
15.9M 51.2M 52.7M 60.9M 3.7M 4.2M 8.2M 24.1M 20182019202020212022202320242025
Net debt ($)
-$141.2M -$167.4M 20182019202020212022202320242025
Share buybacks ($)
20182019202020212022202320242025
Return on assets (%)
-33.20% -39.50% -72.60% -14.50% -46.90% -38.40% 5.30% -29.60% 20182019202020212022202320242025
Free cash flow margin (%)
20182019202020212022202320242025
Debt / equity (×)
0.03× 0.37× 20182019202020212022202320242025
EPS ($)
-$0.52 -$38.10 -$15.96 $1.04 -$3.56 20182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Operating margin-152.2%-38.1%-89.8%-248.3%-34.1%-452.2%-8.1%-440.2%
Net margin-133.4%10.4%-125.8%-444.8%-26.5%-448.9%-8.7%-423.0%
Return on assets-29.6%5.3%-38.4%-46.9%-14.5%-72.6%-39.5%-33.2%
Return on equity-49.6%12.7%-325.1%-184.7%-33.6%-245.4%-67.1%-115.2%
Debt / equity———0.37×0.03×———
Current ratio13.326.342.733.344.502.467.198.22

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.